Patents
Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
02/1998
02/04/1998CN1172483A Substituted heterocyclic compounds, preparation method thereof and pharmaceutical compositions containing same
02/04/1998CN1172435A Use of non-mammalian DNA virus to express exogenous gene in mammalian cell
02/04/1998CN1172116A Aprotinin variants having improved properties
02/04/1998CN1171947A Drug preparation for curing viral and many kinds of myocarditis, low fever and hypokalemia
02/03/1998US5714485 Piperidine and hexahydropyridazine thrombin inhibitors
02/03/1998US5714477 Homogenous, aqueous solution containing fatty monoglyceride; enhanced absorption/bioavailability, drug delivery
02/03/1998US5714370 Pharmaceutical preparation comprising virus-safe human or animal thrombin, coagulatively active salt
02/03/1998US5714353 Safe vectors for gene therapy
02/03/1998US5714333 Process for preparing clear sera which are stable over a long period
02/03/1998CA1339660C Derivatives of cyclohexane
01/1998
01/29/1998WO1998003665A1 Human kallikrein
01/29/1998WO1998003554A1 Synthetic polysaccharides, preparation method therefor and pharmaceutical compositions containing same
01/29/1998WO1998003511A1 New triazolopurines, method of preparing them and their use as drugs
01/29/1998WO1998003502A1 Substituted 2(2,6-dioxopiperidin-3-yl)phthalimides and -1-oxoisoindolines and method of reducing tnf-alpha levels
01/29/1998WO1998003484A1 Substituted pyridines as selective cyclooxygenase-2 inhibitors
01/29/1998DE19629378A1 Neue Triazolopurine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel Triazolopurine new, processes for their preparation and their use as medicaments
01/29/1998CA2261013A1 Human kallikrein
01/29/1998CA2256736A1 New triazolopurines, method of preparing them and their use as drugs
01/28/1998EP0821007A2 Aprotinin variants with improved properties
01/28/1998EP0820455A1 5H, 10H-IMIDAZO [1,2-a]INDENO [1,2-e]PYRAZIN-4-ONE DERIVATIVES, PREPARATION THEREOF, AND DRUGS CONTAINING SAID DERIVATIVES
01/28/1998EP0820453A1 Thrombin inhibitors
01/28/1998EP0820309A2 Engraftment of hematopoietic cells from a primate donor to a primate recipient
01/28/1998EP0820292A1 Inhibition of c. difficile infections by indigestible oligosaccharides
01/28/1998EP0820287A1 Thrombin inhibitors
01/28/1998CN1171791A Purified thrombopoietin and method of making it
01/28/1998CN1171743A Novel tumor suppressor gene HIC-1
01/28/1998CN1171255A Chinese medicine for preventing and curing apoplexy and compounding process thereof
01/28/1998CN1037201C 多元溶剂清洗系统 Multiple solvent cleaning system
01/28/1998CN1037176C Benzenealkanoic acids for cardiovascular diseases
01/27/1998US5712370 Erythropoietin (EPO) peptides and antibodies directed against these
01/27/1998US5712291 Methods and compositions for inhibition of angiogenesis
01/27/1998CA1339645C Pyridinium derivatives, their production and use
01/25/1998CA2207071A1 Aprotinin variants having improved properties
01/22/1998WO1998002548A2 Infectious papillomavirus pseudoviral particles
01/22/1998WO1998002454A2 Conjugates of soluble peptidic compounds with membrane-binding agents
01/22/1998WO1998002190A2 Cationic amphiphile/dna complexes
01/22/1998WO1998002162A1 Heterocyclic compounds with thrombolytic activity and their use for treating thrombosis
01/22/1998DE19730990A1 New (amidino-phenyl)-(benzo:dioxolo-methyl)oxo-pyrrolo:pyrrole compounds
01/22/1998CA2260965A1 Heterocyclic compounds with thrombolytic activity and their use for treating thrombosis
01/22/1998CA2260288A1 Conjugates of soluble peptidic compounds with membrane-binding agents
01/22/1998CA2260034A1 Cationic amphiphile/dna complexes
01/22/1998CA2257822A1 Infectious papillomavirus pseudoviral particles
01/21/1998EP0819136A1 Mdp derivatives and conjugates having haematopoietic function stimulating activity, and compositions containing same
01/21/1998CN1171116A N-substituted glycine derivatives as inhibotors of factor Xa
01/21/1998CN1170601A Pure Chinese drug for curing cerebral thrambus
01/20/1998US5710253 Method for decoloring human serum albumin
01/20/1998US5710140 Phenyl heterocycles as COX-2 inhibitors
01/20/1998US5710131 Protein isolated from extract of hirudo medicinalis (leech)
01/20/1998US5710130 Heterocyclic synthetic peptides
01/20/1998CA2059000C Fused-ring aryl substituted imidazoles
01/15/1998WO1998001554A2 Secreted proteins and polynucleotides encoding them
01/15/1998WO1998001552A2 Secreted proteins and polynucleotides encoding them
01/15/1998WO1998001428A1 AMIDINOINDOLES, AMIDINOAZOLES, AND ANALOGS THEREOF AS INHIBITORS OF FACTOR Xa AND OF THROMBIN
01/15/1998WO1998001422A1 New amidino derivatives and their use as thrombin inhibitors
01/15/1998WO1998001158A2 Haemoglobin-hydroxyethyl starch conjugates as oxygen carriers
01/15/1998WO1998001153A1 Medicinal compositions for extracorporeal blood circulation circuit and method for inhibiting blood coagulation in extracorporeal blood circulation circuit
01/15/1998WO1997032989A3 Recombinant aav vector-based transduction system and use of same
01/15/1998DE19628705A1 Neue Sauerstoff-Transport-Mittel, diese enthaltende Hämoglobin-Hydroxyethylstärke-Konjugate, Verfahren zu deren Herstellung, sowie deren Verwendung als Blutersatzstoffe New oxygen transfer agent containing them hemoglobin-hydroxyethylstarch conjugates, processes for their preparation, and to their use as blood substitutes
01/15/1998CA2260295A1 Secreted proteins and polynucleotides encoding them
01/15/1998CA2260190A1 New amidino derivatives and their use as thrombin inhibitors
01/15/1998CA2259957A1 Secreted proteins and polynucleotides encoding them
01/15/1998CA2259955A1 Secreted proteins and polynucleotides encoding them
01/15/1998CA2259573A1 Amidinoindoles, amidinoazoles, and analogs thereof as inhibitors of factor xa and of thrombin
01/15/1998CA2258947A1 Haemoglobin-hydroxyethyl starch conjugates as oxygen carriers
01/14/1998EP0818459A2 Carbohydrate derivatives
01/14/1998EP0817772A1 Pyrrolidinyl hydroxamic acid compounds and their production process
01/14/1998EP0817642A1 $g(b)-SHEET MIMETICS AND USE THEREOF AS INHIBITORS OF BIOLOGICALLY ACTIVE PEPTIDES OR PROTEINS
01/14/1998EP0817639A1 Pharmaceutical composition containing selected lanthanum carbonate hydrates
01/14/1998EP0817627A1 Protein kinase c inhibitors
01/14/1998EP0817614A1 Stable protein:phospholipid compositions and methods------------
01/14/1998EP0662950B1 Benzenealkanoic acids for cardiovascular diseases
01/14/1998EP0655060B1 Pharmaceutically active diketopiperazines
01/14/1998EP0651738B1 Natural amino acid derivatives as metalloproteinase inhibitors
01/14/1998CN1169993A Use of theophylline derivatives for curing and preventing shock state, xanthine derivatives and preparation thereof
01/13/1998US5708157 Secreted proteins and polynucleotides encoding them
01/13/1998US5707989 Pyrimido 5,4-D!pyrimidines, medicaments comprising these compounds, their use and processes for their preparation
01/13/1998US5707972 Polysaccharides and anesthetics and/or microbiocides for wound healing agents
01/13/1998US5707635 Containing a crosslinked polyacrylamide-type polymer and an active compound, optionally a humectant and an emollient
01/08/1998WO1998000443A1 Thrombin inhibitors
01/08/1998WO1998000439A2 Multivalent compounds for cross-linking receptors and uses thereof
01/08/1998WO1998000395A1 Phenylalamine derivatives as integrin inhibitors
01/08/1998WO1998000171A2 Conjugates of thrombin inhibitors and endogenes carriers
01/08/1998WO1998000134A1 Fibrinogen receptor antagonists
01/08/1998CA2259224A1 Phenylalamine derivatives as integrin inhibitors
01/08/1998CA2258516A1 Conjugates of thrombin inhibitors and endogenes carriers
01/08/1998CA2258093A1 Fibrinogen receptor antagonists
01/08/1998CA2258038A1 Multivalent compounds for cross-linking receptors and uses thereof
01/07/1998EP0816497A2 Human requiem polypeptide for apoptosis
01/07/1998EP0816495A1 DNA coding for a peptide promoting the activation of protein C by thrombin and dprocess for producing the same
01/07/1998EP0816494A1 DNA coding for a peptide promoting the activation of protein C by thrombin, and process for producing the same
01/07/1998EP0816493A1 3'End deleted DNA coding for a peptide promoting the activation of protein C by thrombin, and process for producing the same
01/07/1998EP0816376A1 Trombin inhibitors as anticoagulant agents
01/07/1998EP0816343A1 Process for the preparation of chiral, non-racemic (4-aryl-2,5-dioxoimidazolin-1-yl)-acetic acids
01/07/1998EP0815866A2 Platelet membrane fragment preparation
01/07/1998EP0815252A1 Gene therapy for transplantation and inflammatory or thrombotic conditions
01/07/1998EP0815247A1 Method for the production of cationic peptides
01/07/1998EP0815232A1 Protein production and delivery
01/07/1998EP0815139A1 Thrombin inhibitors based on the amino acid sequence of hirudin
01/07/1998EP0815138A1 Stable polymerized hemoglobin blood-substitute
01/07/1998EP0815127A1 Fucopeptides